Your browser doesn't support javascript.
loading
TRIL is involved in cytokine production in the brain following Escherichia coli infection.
Wochal, Paulina; Rathinam, Vijay A K; Dunne, Aisling; Carlson, Thaddeus; Kuang, Wen; Seidl, Katherine J; Hall, J Perry; Lin, Lih-Ling; Collins, Mary; Schattgen, Stefan A; MacKay, Christopher R; Fagundes, Caio T; Carpenter, Susan; Fitzgerald, Katherine A; O'Neill, Luke A J.
Afiliação
  • Wochal P; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland;
  • Rathinam VA; Division of Infectious Disease and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605;
  • Dunne A; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland;
  • Carlson T; Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02140; and.
  • Kuang W; Global Biotherapeutic Technologies, Pfizer, Andover, MA 01810.
  • Seidl KJ; Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02140; and.
  • Hall JP; Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02140; and.
  • Lin LL; Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02140; and.
  • Collins M; Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02140; and.
  • Schattgen SA; Division of Infectious Disease and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605;
  • MacKay CR; Division of Infectious Disease and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605;
  • Fagundes CT; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland;
  • Carpenter S; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Division of Infectious Disease and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605;
  • Fitzgerald KA; Division of Infectious Disease and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605;
  • O'Neill LA; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; laoneill@tcd.ie.
J Immunol ; 193(4): 1911-9, 2014 Aug 15.
Article em En | MEDLINE | ID: mdl-25015823
ABSTRACT
TLR4 interactor with leucine-rich repeats (TRIL) is a brain-enriched accessory protein that is important in TLR3 and TLR4 signaling. In this study, we generated Tril(-/-) mice and examined TLR responses in vitro and in vivo. We found a role for TRIL in both TLR4 and TLR3 signaling in mixed glial cells, consistent with the high level of expression of TRIL in these cells. We also found that TRIL is a modulator of the innate immune response to LPS challenge and Escherichia coli infection in vivo. Tril(-/-) mice produce lower levels of multiple proinflammatory cytokines and chemokines specifically within the brain after E. coli and LPS challenge. Collectively, these data uncover TRIL as a mediator of innate immune responses within the brain, where it enhances neuronal cytokine responses to infection.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Proteínas de Transporte / Receptor 3 Toll-Like / Receptor 4 Toll-Like / Imunidade Inata / Proteínas de Membrana Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Proteínas de Transporte / Receptor 3 Toll-Like / Receptor 4 Toll-Like / Imunidade Inata / Proteínas de Membrana Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article